Loading...

FATE FATE THERAPEUTICS INC Management Changes 8-K Filing

FT T

FT

FATE THERAPEUTICS INC

(FATE)

2025 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Management Changes

Management Changes

Financial Results

Indemnification Agreement

Financial Results

Board Increase and Appointm...

Amendment Approval

Appointment of CFO

Resignation and Appointment

Financial Results Announcement

Phase 1 Study Results

Equity Offering

Financial Results Announcement

Registration Statement and ...

Earnings Reports

Litigation Update

Earnings Report

Annual Meeting Results

Resignation of CMO

Presentation at Jefferies H...

Earnings Reports

Amendment to Certificate of...

Financial Results Announcement

Termination of Collaboratio...

External Links:

On May 29, 2025, Fate Therapeutics, Inc. appointed Matthew Abernethy to its board and approved an increase in authorized shares from 250 million to 350 million. The stockholders also approved amendments to its stock option plan, allowing an additiona

AI Assistant

FATE THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.